JCRファーマの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2019/07/30 | 7,260 | 7,490 | 7,250 | 7,480 | +340 | +4.8% | 187,900 |
2019/07/29 | 7,100 | 7,220 | 7,060 | 7,140 | +140 | +2% | 87,000 |
2019/07/26 | 6,980 | 7,400 | 6,960 | 7,000 | -180 | -2.5% | 229,600 |
2019/07/25 | 7,130 | 7,230 | 7,090 | 7,180 | +70 | +1% | 99,100 |
2019/07/24 | 7,150 | 7,170 | 7,040 | 7,110 | +50 | +0.7% | 92,300 |
2019/07/23 | 6,900 | 7,100 | 6,880 | 7,060 | +210 | +3.1% | 127,600 |
2019/07/22 | 6,750 | 6,920 | 6,710 | 6,850 | +90 | +1.3% | 103,100 |
2019/07/19 | 6,630 | 6,780 | 6,630 | 6,760 | +130 | +2% | 66,100 |
2019/07/18 | 6,670 | 6,710 | 6,610 | 6,630 | -90 | -1.3% | 88,800 |
2019/07/17 | 6,780 | 6,800 | 6,640 | 6,720 | -150 | -2.2% | 140,100 |
2019/07/16 | 6,660 | 6,870 | 6,620 | 6,870 | +170 | +2.5% | 116,600 |
2019/07/12 | 6,730 | 6,750 | 6,630 | 6,700 | +130 | +2% | 135,000 |
2019/07/11 | 6,610 | 6,640 | 6,550 | 6,570 | +50 | +0.8% | 53,300 |
2019/07/10 | 6,390 | 6,550 | 6,390 | 6,520 | +80 | +1.2% | 51,400 |
2019/07/09 | 6,470 | 6,470 | 6,370 | 6,440 | +20 | +0.3% | 61,500 |
2019/07/08 | 6,490 | 6,490 | 6,340 | 6,420 | -70 | -1.1% | 61,100 |
2019/07/05 | 6,670 | 6,670 | 6,470 | 6,490 | -150 | -2.3% | 48,800 |
2019/07/04 | 6,580 | 6,700 | 6,580 | 6,640 | +90 | +1.4% | 68,500 |
2019/07/03 | 6,640 | 6,730 | 6,470 | 6,550 | +10 | +0.2% | 122,800 |
2019/07/02 | 6,460 | 6,580 | 6,460 | 6,540 | +110 | +1.7% | 85,900 |
2019/07/01 | 6,350 | 6,440 | 6,300 | 6,430 | +160 | +2.6% | 67,500 |
2019/06/28 | 6,230 | 6,280 | 6,210 | 6,270 | ±0 | ±0% | 47,200 |
2019/06/27 | 6,300 | 6,330 | 6,230 | 6,270 | +10 | +0.2% | 48,000 |
2019/06/26 | 6,370 | 6,400 | 6,230 | 6,260 | -150 | -2.3% | 84,500 |
2019/06/25 | 6,300 | 6,500 | 6,300 | 6,410 | +60 | +0.9% | 51,000 |
2019/06/24 | 6,390 | 6,400 | 6,280 | 6,350 | -40 | -0.6% | 44,500 |
2019/06/21 | 6,600 | 6,600 | 6,370 | 6,390 | -190 | -2.9% | 101,300 |
2019/06/20 | 6,450 | 6,610 | 6,450 | 6,580 | +150 | +2.3% | 74,800 |
2019/06/19 | 6,390 | 6,460 | 6,370 | 6,430 | +120 | +1.9% | 56,800 |
2019/06/18 | 6,320 | 6,420 | 6,310 | 6,310 | -30 | -0.5% | 59,300 |
2019/06/17 | 6,360 | 6,390 | 6,310 | 6,340 | -60 | -0.9% | 53,800 |
2019/06/14 | 6,410 | 6,430 | 6,360 | 6,400 | ±0 | ±0% | 43,700 |
2019/06/13 | 6,460 | 6,460 | 6,360 | 6,400 | -100 | -1.5% | 46,300 |
2019/06/12 | 6,520 | 6,590 | 6,490 | 6,500 | +10 | +0.2% | 57,300 |
2019/06/11 | 6,600 | 6,620 | 6,450 | 6,490 | -100 | -1.5% | 87,000 |
2019/06/10 | 6,440 | 6,640 | 6,440 | 6,590 | +210 | +3.3% | 116,400 |
2019/06/07 | 6,330 | 6,400 | 6,250 | 6,380 | +20 | +0.3% | 125,200 |
2019/06/06 | 6,470 | 6,540 | 6,360 | 6,360 | -20 | -0.3% | 106,900 |
2019/06/05 | 6,470 | 6,500 | 6,330 | 6,380 | +10 | +0.2% | 161,800 |
2019/06/04 | 6,560 | 6,580 | 6,260 | 6,370 | -200 | -3% | 159,700 |
2019/06/03 | 6,740 | 6,780 | 6,570 | 6,570 | -230 | -3.4% | 82,600 |
2019/05/31 | 6,890 | 6,900 | 6,730 | 6,800 | +110 | +1.6% | 180,300 |
2019/05/30 | 6,740 | 6,820 | 6,590 | 6,690 | -140 | -2% | 134,500 |
2019/05/29 | 7,040 | 7,130 | 6,790 | 6,830 | -390 | -5.4% | 239,200 |
2019/05/28 | 7,090 | 7,250 | 7,090 | 7,220 | +130 | +1.8% | 102,000 |
2019/05/27 | 7,050 | 7,120 | 7,030 | 7,090 | +70 | +1% | 53,300 |
2019/05/24 | 7,030 | 7,070 | 6,970 | 7,020 | -120 | -1.7% | 63,400 |
2019/05/23 | 6,940 | 7,190 | 6,910 | 7,140 | +180 | +2.6% | 77,700 |
2019/05/22 | 7,200 | 7,230 | 6,940 | 6,960 | -210 | -2.9% | 104,600 |
2019/05/21 | 7,060 | 7,230 | 7,050 | 7,170 | +60 | +0.8% | 80,000 |
1301~
1350
件表示中 / 6840件
類似銘柄と比較する
現在ご覧いただいている「JCRファーマ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
JCRファーマ | 72,400円 | -3.7% | -36.7% | 2.76% | 23.84倍 | 1.56倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
ネクセラファーマ | 113,200円 | +197.7% | - | 0.00% | 46.26倍 | 1.48倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
杏林製薬 | 149,900円 | +3.2% | +4.5% | 3.47% | 17.22倍 | 0.66倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
栄研化 | 209,200円 | +0.4% | -8.4% | 2.53% | 27.65倍 | 1.57倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
サンバイオ | 96,500円 | - | - | 0.00% | - | 48.59倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
市場注目の銘柄
チャート関連のコラム